Assesssment of the effect of pretreatment with neoadjuvant therapy on primary breast cancer.

Patients with invasive cancer of the breast (T1-4, N0-2, M0) were assigned to pretreatment based on oestrogen receptor (ER) status; patients with ER-negative tumours received chemotherapy [mitozantrone, methotrexate and mitomycin C (MMM)] for 3 months, patients with ER-positive tumours underwent end...

Descripción completa

Detalles Bibliográficos
Autores principales: Gazet, J. C., Coombes, R. C., Ford, H. T., Griffin, M., Corbishley, C., Makinde, V., Lowndes, S., Quilliam, J., Sutcliffe, R.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1996
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074387/
https://www.ncbi.nlm.nih.gov/pubmed/8611376

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074387/
https://www.ncbi.nlm.nih.gov/pubmed/8611376

Ejemplares similares